Month: March 2012

London, 30 mar (EFE).-scientific British have discovered an enzyme which medications to combat acute myeloid leukemia, a very aggressive cancer with a percentage go low survival, explained to Efe researcher Tim Somervaille. 2.380 Cases of this disease, which produces a decrease in red blood cells and platelets in the blood and whose incidence increases with age are diagnosed each year in the United Kingdom. Currently, 40 percent of the patients under sixty years achieved disease survive five years or more after having been diagnosed. A team of Paterson Institute for Cancer Research at the English University of Manchester discovered that this enzyme, called LSD1, helps to control if the genes responsible for this cancer are activated or not. According to the experts, block this enzyme would prevent the production of proteins that drive the disease, which is a “totally new” approach in dealing with this ailment, as detailed Somervaille, of the public organization, Cancer Research UK. Thanks to this finding, this agency experts managed to curb the growth of the leukemia cells in samples taken from mice and human, for which he used a set of molecules that stopped the activity of the enzyme responsible for. “Have found a new target, an enzyme in cells, where it inhibits causing leukemia cells stop growing.” “We are very excited,” said Efe Somervaille, following the publication of an article on the study...

Zaragoza ( Spain), 30 mar ( EFE).-A 70 percent of smokers have alterations in the arteries, as it finds a cardiovascular prevention study involving almost 6,000 workers Spaniards, whom they were taken already 280,000 samples of DNA, blood, serum and urine. Research, so-called “Aragon Workers ' s Health Study”, it occurs from three years between the Aragonese Institute of Health Sciences (IACS) and the national centre of cardiovascular research (CNIC), and is intended to meet, since its inception, the evolution of cardiovascular diseases, said today its Coordinator, José Antonio Casasnovas. The researcher noted in press conference that the Studio, the largest in Europe and uses very innovative techniques, reveals that 40 years are beginning to see alterations in the arteries, so the arterioresclerosis is “earlier” than I thought. However, it is unknown whether these alterations are natural, physiological or will condition a disease, which is what they now have to analyse, added. Of the participants in the study (workers at the plant of General Motors in Figueruelas, Zaragoza), 30 percent have hypertension, the 25 per cent obesity and 3.5 percent diabetes, said Montserrat León, the IACS and clinical Coordinator of the project. According to Lion of 500 women studied in that group, 45 percent were smokers and men, 37 percent. Researcher referred to smoking as the main responsible for cardiovascular disorders. In fact, the research found that 70 percent...

London, 30 mar (EFE).-scientific British have discovered an enzyme which medications to combat acute myeloid leukemia, a very aggressive cancer with a percentage go low survival, explained to Efe researcher Tim Somervaille. 2.380 Cases of this disease, which produces a decrease in red blood cells and platelets in the blood and whose incidence increases with age are diagnosed each year in the United Kingdom. Currently, 40 percent of the patients under sixty years achieved disease survive five years or more after having been diagnosed. A team of Paterson Institute for Cancer Research at the English University of Manchester discovered that this enzyme, called LSD1, helps to control if the genes responsible for this cancer are activated or not. According to the experts, block this enzyme would prevent the production of proteins that drive the disease, which is a “totally new” approach in dealing with this ailment, as detailed Somervaille, of the public organization, Cancer Research UK. Thanks to this finding, this agency experts managed to curb the growth of the leukemia cells in samples taken from mice and human, for which he used a set of molecules that stopped the activity of the enzyme responsible for. “Have found a new target, an enzyme in cells, where it inhibits causing leukemia cells stop growing.” “We are very excited,” said Efe Somervaille, following the publication of an article on the study...